Additionally, this could serve as a valuable biological tool and strategy to investigate the benefits of determining GFAP and UCH-L1 levels in the blood for other neurological conditions such as severe TBI [25], stroke [26], and intracranial pressure [27]. This evidence concerns the gene UCHL1 and stroke disorder.